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Abstract
Background: Chromosome translocation associated with neurodevelopmental disorders provides an opportunity
to identify new disease-associated genes and gain new insight into their function. During chromosome analysis,
we identified a reciprocal translocation between chromosomes 1p and 12q, t(1; 12)(p32.1; q21.3), co-segregating
with microcephaly, language delay, and severe psychomotor retardation in a mother and her two affected boys.
Methods: Fluorescence in situ hybridization (FISH), long-range PCR, and direct sequencing were used to map the
breakpoints on chromosomes 1p and 12q. A reporter gene assay was conducted in human neuroblastoma (SKNSH)
and Chinese hamster ovary (CHO) cell lines to assess the functional implication of the fusion sequences between
chromosomes 12 and 1.
Results: We determined both breakpoints at the nucleotide level. Neither breakpoint disrupted any known gene
directly. The breakpoint on chromosome 1p was located amid a gene-poor region of ~ 1.1 Mb, while the breakpoint on
chromosome 12q was located ~ 3.4 kb downstream of the ALX1 gene, a homeobox gene. In the reporter gene assay,
we discovered that the fusion sequences construct between chromosomes 12 and 1 had a ~ 1.5 to 2-fold increased
reporter gene activity compared with the corresponding normal chromosome 12 sequences construct.
Conclusion: Our findings imply that the translocation may enhance the expression of the ALX1 gene via the
position effect and result in the clinical symptoms of this family. Our findings may also expand the clinical
phenotype spectrum of ALX1-related human diseases as loss of the ALX1 function was recently reported to result
in abnormal craniofacial development.
Background
Mental retardation (MR) is a childhood-onset neurode-
velopmental disorder characterized by a reduced intel-
lectual function that results in learning disability and
impaired social adaptation. Approximately 2-3% of the
general population is affected with MR; and males are
more often affected than females [1]. Genetic defects
including gross structural abnormalities of chromo-
somes, cryptic genomic rearrangements, and monogenic
mutations are the leading cause of MR [2,3]. Numerous
genes with diversified biological functions have been
found to be associated with syndromic and non-syndro-
mic MR; moreover, most of the genetic mutations caus-
ing MR are rare, private mutations, indicating that the
genetic etiology of MR comprises a variety of highly het-
erogeneous genetic defects [2,3]. Despite the fact that
many genes have been identified as being associated
with MR, more MR genes remain to be discovered [2-4].
Chromosomal rearrangements associated with MR
may provide an opportunity to discover novel genes
associated with this condition. Chromosomal transloca-
tions may lead to clinical phenotypes via direct gene dis-
ruption, formation of chimera genes, or alteration of the
expression of genes near the breakpoint via the position
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any medium, provided the original work is properly cited.effect [5-7]. Several MR-associated genes have been dis-
covered through mapping of the breakpoints of chromo-
somal translocations, such as the dedicator of
cytokinesis 8 gene (DOCK8) at 9p24 [8]; the potassium
large conductance calcium-activated channel, subfamily
M, alpha member 1 gene (KCNMA1) at 10q22.3 [9]; the
autism susceptibility candidate 2 gene (AUTS2) at
7q11.2 [10]; the oligophrenin 1 gene (OPHN1) at Xq12
[11]; the Cdc42 guanine nucleotide exchange factor
(GEF) 9 (ARHGEF9) at Xq11.1 [12]; and the reelin gene
(RELN) at 7q22 [13].
As part of serial genetic studies of mental retardation,
we detected a reciprocal translocation between chromo-
some 1p and 12q in the karyotype analysis of a family
affected with severe MR, language delay and microce-
phaly. The translocation was transmitted from the
mother to her two boys and co-segregated with the phe-
notypes. Herein we report the clinical phenotypes and
the molecular characterization of the translocation asso-
ciated with the phenotypes in this family.
Methods
The Taiwanese family was ascertained through the psy-
chiatric clinic of Tzu-Chi General Hospital, Hualien,
Taiwan. The family received medical attention due to
the psychomotor retardation of the eldest boy of the
family. All family members gave their written consent
after all the details of the study were fully explained.
Karyotype and FISH analysis
Karyotype analysis was performed using the standard
GTW-banding method. The breakpoints of chromoso-
mal translocation were investigated using FISH on the
metaphase chromosome spreads according to the stan-
dard protocol [14].
Breakpoints identification with PCR and autosequencing
The breakpoint regions were mapped by long-range PCR
using the rTth DNA Polymerase XL kit (Applied Biosys-
tems, Foster City, California) according to the manufac-
turer’s protocol. A set of primers were used to PCR
amplify the breakpoint regions of the derivative chromo-
somes 1 and 12, respectively. Aliquots of PCR products
that contain the breakpoints were processed using the
PCR Pre-Sequencing Kit (USB Cleveland), and subjected
to direct sequencing using the ABI Prism™ BigDye™ Ter-
minator Cycle Sequencing Ready Reaction Kit Version 3.1
and the ABI Autosequencer 3730 (Perkin Elmer Applied
Biosystems), following the manufacturers’ protocols.
Real-time quantitative PCR (RT-qPCR)
Total RNA was prepared from cell lines and tissues
using TRIzol Reagents (Invitrogen Life Technologies,
Cartsbad, CA), and cDNA was generated using
Superscript II RNase H
- Reverse Transcriptase (Invitro-
gen Life Technologies, Carlsbad, CA). Real-time quanti-
tative PCR (RT-qPCR) was performed using an Applied
Biosystems PRISM 7300 Sequence Detection System
with continuous SYBR Green detection (Applied Biosys-
tems, Foster City, California). Relative quantification
with the standard curve method was used to determine
the expression level of the gene of interest. The expres-
sion level of each gene was normalized by the expres-
sion level of 18S rRNA in each sample, which was
measured using Pre-Developed TaqMan Assay Reagents
18S rRNA MGB, according to the manufacturer’s proto-
col (Applied Biosystems, Foster City, California).
Reporter Gene Activity Assay
An amplicon (1302 bp) comprising 232 bp of chromo-
some 12 and 1070 bp of chromosome 1 was PCR-ampli-
fied from the genomic DNA of affected subjects using
primer sets (Chr12-84222865 F-BamHI and Chr1-
60785185 R, see Table 1) and cloned into the 3’ end of
the reporter gene pGL3-control vector (Promega, Madi-
son, WI, USA). The corresponding normal chromosome
12 sequences were also PCR-amplified (1371 bp) from
unaffected subjects using primer sets (Chr12-84222865
F-BamHI and Chr12-84224235 R, see Table 1) and
cloned into the 3’ end of the pGL3-control vector
BamHI site for comparison. Transfection of the plas-
mids containing each of these three different constructs
were performed in a SKNSH neuroblastoma cell line
and in Chinese hamster ovary cells (CHO) cultured in
Minimum Essential Medium (MEM) containing 5% fetal
bovine serum in 24-well plates using Lipofeta-
mine™2000 (Invitrogen, California, USA) according to
the manufacturer’s protocol. At 48 h after transfection,
the cells were lysed and the luciferase activities were
measured using the Dual-Luciferase Reporter Assay Sys-
tem, according to the manufacturer’si n s t r u c t i o n s( P r o -
mega, Madison, WI, USA). The firefly luciferase activity
was normalized against the Renilla luciferase activity in
each transfection, and reported as the relative luciferase
ratio. The differences in gene expression activity
between the two constructs were analyzed using a t-test,
while differences among the three groups were evaluated
by analysis of variance (ANOVA) followed by post-hoc
comparison; the p value was set at 0.05.
Results
Clinical findings
We identified a Taiwanese family affected with severe
mental retardation, language delay, and microcephaly in
the mother and her two boys (Figure 1A). The proband
was a boy who was 6 years old boy when he was first
referred to the geneticist, primarily for severe psycho-
motor retardation and language delay. Physical
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phaly with frontal narrowing, a flat philtrum, and bilat-
eral epicanthal folds. His head circumference was 47
cm, which was below three standard deviations from the
mean of his age in our population. His height was at the
25th percentile, while his body weight was between the
50th to 75th percentile. No seizure history was detected.
He was born spontaneously at full term with an
uneventful pregnancy. The details of his birth history
were not available beyond that his birth weight was
2800 g. The Chinese-language version of the Denver
Developmental Screening Test (DDST) conducted at 6
years old showed that he had severe psychomotor retar-
dation and a mental age of about 2 years. At the age of
9, he was given the Chinese version of the Wechsler
Intelligence Scale for Children-Third Edition (WISC-III),
which showed that he had moderate MR with a verbal
intelligence quotient (IQ) score of 46, performance IQ
Table 1 Primer sequences and their nucleotide positions on chromosomes 1 and 12 to amplify the breakpoint regions
using PCR, and for construction of the expression vectors for the reporter gene assay
primer name primer location sequences (5’-3’)
Chr1-6 Chr1:61006139-61006163 5’-AGCTTTAACACGGGAGTATAAGGTT-3’
Chr12-5 Chr12:85690331-85690355 5’-CTAATGGGAGGTAGTTGGCTAAGTT-3’
Chr1-6-6 Chr1:61012306-61012330 5’-CTGCAGTCAGACAGATCTAAGATCA-3’
Chr12-5-8 Chr12:85698309-85698333 5’-ACAGTTCTTCTCAAGACAATATGCC-3’
Chr1-Narrow F Chr1:61013248-61013272 5’-ACTCACTGTGACCCTATGATTTAAG-3’
Chr12-Narrow F Chr12:85698739-85698763 5’-CCTCCATCTGTTTTATGTAATGCTG-3’
Chr1-Narrow R Chr1:61013944-61013964 5’-CGGCTGTACACATAGCTACCA-3’
Chr12-Narrow R Chr12:85699656-85699675 5’-TCATTTATTTGCCCCTTGGA-3’
Chr12-84222865 F-BamHI Chr12:85698734-85698753 5’-ATAGGATCCCCCAGCCTCCATCTGTTTTA-3
Chr1-60785185 R Chr1:61012577-61012597 5’-ATAGGATCTTTGGTCAACAATGACTGCAT-3’
Chr12-84224235 R Chr12:85700085-85700104 5’-ATAGGATCTTGGGGACAAATTCACAGGT-3’
Figure 1 The results of Karyotype and FISH analysis. (A) Pedigree of the family with mental retardation, language delay and microcephaly.
(B) Standard karyotype analysis revealed a reciprocal translocation between chromosomes 1 and 12, designated t(1, 12)(p32.1; q21.2) in the
proband (II-1). (C) FISH analysis showed the chromosome 1 breakpoint may be located within the genomic sequences of the BAC clone RP11-
57F6, as the fluorescent signal could be seen on normal chromosome 1, derivative chromosome 1, and derivative chromosome 12. (D) FISH
analysis showed that the chromosome 12 breakpoint may be located within the genomic sequences of the BAC clone RP11-259D24, as the
fluorescent signal could be seen on normal chromosome 12, derivative chromosome 1, and derivative chromosome 12.
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Page 3 of 8score of 49, and full IQ score of 47. At the age of 10, a
brain magnetic resonance imaging (MRI) analysis of the
proband showed no abnormality.
His mother was also found to have severe MR, limited
language, and microcephaly. The father was unrelated to
the mother, had normal intelligence and had a job.
However, he reported that he had a family history of
depression. The second boy in this family had normal
intelligence and developmental milestones; however, the
third boy also suffered from severe psychomotor retar-
dation and microcephaly. At the age of 5 years and 7
months, the third boy had head circumference of 45 cm,
which was below the 3rd percentile. The Chinese-lan-
guage version of the DDST administered at that time
also showed that this boy had severe psychomotor retar-
dation and a mental age of about 2 years. He was found
to have tics at the age of 7. At the age of 9 years, brain
MRI study showed that this boy had hypoplasia of the
frontal brain lobes and anterior portion of the corpus
callosum. The maternal grandmother of this family was
reported to have mental retardation too; and the
affected mother had a younger brother who was
reported to have normal intelligence. However, neither
of them was available for this study.
Karyotype and FISH analysis
K a r y o t y p ea n a l y s i so ft h i sf a m i l ys h o w e dar e c i p r o c a l
chromosomal translocation between chromosomes 1p
and 12q, t(1;12)(p32.1;q21.3), co-segregating with the
affected members in this family (Figure 1B). The father
and the second boy, both of whom were normal in
intelligence, had normal karyotypes. We conducted
FISH analysis to fine map the breakpoint regions of the
reciprocal translocation. Two BAC clones that span the
respective breakpoints of the translocation on chromo-
somes 1 and 12 were identified. As shown in Figure 1C,
the fluorescent signal of BAC RP11-57F6 (GenBank
accession numbers: AQ194822 and AQ115454) was
detected in normal chromosome 1, derivative chromo-
some 1, and derivative chromosome 12, indicating that
the chromosome 1 breakpoint was located within the ~
140 kb genomic sequences of RP11-57F6. Similarly, the
fluorescent signal of RP11-259D24 (GenBank access
numbers AQ483628 and AZ519051) was present in nor-
mal chromosome 12, derivative chromosome 12, and
derivative chromosome 1 (Figure 1D), indicating the
chromosome 12 breakpoint was located within the ~
140 kb genomic sequences of RP11-259D24.
Breakpoint identification
To identify the breakpoint sequences, we used long-
range PCR to obtain amplicons that contained the
fusion sequences of derivative chromosome 1 and deri-
vative chromosome 12, respectively. We successfully
obtained a PCR amplicon of ~ 16 kb covering the
breakpoint of the derivative chromosome 12 from the
affected members using the primer Chr 12-5 located on
chromosome 12, and the primer Chr 1-6 located on
chromosome 1 (Figure 2A). The breakpoint region was
further defined using the other internal primer sets. At
first, a PCR amplicon of ~ 2 kb was obtained using the
internal primers (Chr 12-5-8 and Chr 1-6-6) (Figure
2B); then a PCR amplicon of ~ 600 bp (Figure 2C) was
obtained using two other internal primer sets (Chr12-
Narrow F and Chr1-Narrow F) (Figure 2C). The ~ 600
bp PCR products were subjected to autosequencing. As
shown in Figure 3A, the breakpoint junction was located
at nucleotide position 85698965 on derivative chromo-
some 12 (Human Genome Sequences, Build 37.1) and at
nucleotide position 61013667 on chromosome 1
(Human Genome Sequences, Build 37.1); there was a
deletion of 3 base pairs (TTG) from derivative chromo-
some 12 in this fusion sequence.
The determination of the breakpoint sequences on
derivative chromosome 12 allowed us to build primer
Figure 2 PCR-based breakpoint identification. (A) Long-range
PCR products of ~ 16 kb covering the breakpoint region of the
derivative chromosome 12. M: DNA size marker; 1. II-1, 2. II-3, 3: I-2,
4: I-1, 5: water blank, 6: positive control for long-range PCR using
genomic DNA as a template, 7. positive control for long-range PCR
using phage lambda as a template. (B) The breakpoint region of
derivative chromosome 12 was further narrowed down to a PCR
product of ~ 2 kb. M: DNA size marker; 1. II-1, 2. II-3, 3: I-2, 4: I-1, 5:
positive control for long-range PCR using genomic DNA as a
template (C). To sequence the breakpoint region, a PCR product of
600 bp covering the breakpoint region of derivative chromosome
12 was generated and subjected to autosequencing. M: DNA size
marker; 1. II-1, 2. II-3, 3: I-2, 4: I-1, 5: water blank. (D) PCR products of
~ 1 kb covering the breakpoint region of derivative chromosome 1
were obtained and subjected to autosequencing. M: DNA size
marker; 1. II-1, 2. II-3, 3: I-2, 4: I-1, 5: water blank.
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PCR to obtain an amplicon of ~ 1 kb that encompassed
the breakpoint region on derivative chromosome 1 (Fig-
ure 2D). The amplicon was sequenced, and the junction
sequences are shown in Figure 3B. The breakpoint junc-
tion included nucleotide position 61013678 on derivative
chromosome 1 (Build 37.1) and nucleotide position
85698969 on chromosome 12 (Build 37.1); there was an
insertion of 19 base pairs in this junction region. All the
affected children had the same breakpoint sequences
that were transmitted from their mother. The sequences
and the locations of the primers used for this molecular
analysis of the breakpoints are listed in Table 1.
Reporter gene assay
In the CHO cells, the fusion construct of chromosomes
12 and 1 had ~ 1.5-fold increased reporter gene activity
compared with the corresponding regular chromosome
12 construct, as shown in Figure 4A. In SKNSH cell
lines, the same fusion construct had ~ 2.0-fold increased
reporter gene activity compared to the corresponding
regular chromosome 12 construct, as shown in Figure
4B.
Discussion
In the present study, we successfully mapped the break-
point sequences of a reciprocal translocation between
chromosome 1 and 12 that co-segregated with mental
retardation, language delay, and microcephaly in a two-
generation family. The breakpoint on chromosome 1
did not disrupt any known gene directly. The genes clo-
sest to this breakpoint included the CYP2J2 gene located
~ 621 Kb centromeric from the breakpoint, and the
NFIA gene located ~ 529 kb telomeric from the break-
point. The chromosome 12 breakpoint did not directly
disrupt any known gene, either. The breakpoint was
Figure 3 The sequences of chromosome 1 and chromosome 12 breakpoint. The sequences flanking the breakpoint junction of derivative
chromosome 12 (A) and derivative chromosome 1 (B) were obtained after autosequencing the PCR amplicons covering the breakpoint regions.
The nucleotide positions of the breakpoints were based on the human genome sequences Build 37.1.
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gene, which was the gene closest to the breakpoint. The
ALX1 gene encodes the aristaless-like homeobox 1 tran-
scription factor that is involved in craniofacial develop-
ment. Disruption of the ALX1 gene was recently
reported to cause an autosomal recessive microphthal-
mia and a severe facial cleft [14]. In this study, ALX1
was considered as a putative candidate gene associated
with the clinical symptoms of this family in view of its
close location to the breakpoint and its biological func-
tion. We hypothesized that the expression of the ALX1
gene might be changed via the position effect by the
translocation [7,15,16]. To test this hypothesis, we first
attempted to measure the mRNA level of the ALX1
gene from lymphoblastoid cells in affected family mem-
bers and control subjects using RT-qPCR; however, the
mRNA level of the ALX1 gene was not detectable in the
lymphoblastoid cells. To assess the influence of the
translocation on ALX1 gene expression, we next con-
ducted a reporter gene assay in Chinese ovary hamster
(CHO) cells and a SKNSH neuroblastoma cell line. The
r e s u l t sf r o mt h i sa s s a ys h o w e dt h a tt h ef u s i o nc o n s t r u c t
between chromosome 12 and 1 had significantly higher
reporter gene activity than the corresponding normal
chromosome 12 sequences, indicating the fusion con-
struct might enhance ALX1 gene expression.
The ALX1 gene, also known as the CART1 gene,
encodes a 326-amino acid cartilage paired-class homeo-
protein 1 that acts as a transcription factor and binds to
palindromic sequences consisting of two TAAT
separated by 3 or 4 base pairs [17]. In rodents, the Alx1
gene is expressed in forebrain mesenchymal cells, bran-
chial arches, limb buds, and chondrocytes during
embryogenesis [18,19]. Homozygous Alx1 gene knock-
out mice did not show bone abnormalities, instead, they
showed defects in neural tube closures that resulted in
acrania, meroanencephaly, and other head abnormalities
[19], while the heterozygous Alx1 knockout mice were
apparently normal [19]. Recently, Uz and colleagues
reported the first human clinical phenotypes associated
with ALX1 gene mutation in two families [14]. They
found that complete loss of the ALX1 function in these
two families seriously disturbed early craniofacial devel-
opment and resulted in severe frontofacionasal dysplasia,
including bilateral extreme microphthalmia, severe facial
cleft, complete palate cleft, and low-set posteriorly
rotated ears; the frontofacionasal dysplasia in these two
families presented in a recessive mode of inheritance. In
one family, the affected family members showed a
homozygous 3.7 Mb deletion containing the ALX1 gene.
In the other family, a homozygous G-to-A mutation at
the donor-splicing site of intron 2 was identified in the
affected patient. The clinical symptoms caused by the
loss-of-function mutations of the ALX1 gene were
related to the clinical spectrum of frontofacionasal dys-
plasia caused by the two other ALX genes, ALX3 and
ALX4. Patients with homozygous mutations in the
ALX3 gene presented distinctive clinical features of
frontofacionasal malformations, including hypertelorism,
wide nasal bridge, bifid nasal tip, broad columella,
widely separate slit-like nares, long philtrum with pro-
minent bilateral swellings, and midline notch in the
upper lip and alveolus, termed frontorhiny [20]. Homo-
zygous mutation in the ALX4 gene was found to be
associated with frontofacionasal dystosis syndrome,
characterized by total alopecia, a large skull defect, coro-
nal craniosynostosis, hypertelorism, a severely depressed
nasal bridge and ridge, a bifid nasal tip, hypogonadism,
callosal body agenesis, and mental retardation [21].
Together, these findings suggest all three ALX family
genes have an essential, non-redundant role in the cra-
niofacial development in humans, and the loss-of-func-
tion mutations of these genes may cause severe cranio-
facial-nasal abnormalities.
Based on the reporter gene assay, we speculate that
the clinical phenotypes of the family in the present
study including severe MR, language delay, and microce-
phaly are likely to be associated with over-expression of
the ALX1 gene, which contrasts with the clinical pheno-
types of the loss-of-function mutation of the ALX1 gene
as reported recently [14]. The pathogenesis of the over-
expression of the ALX1 gene needs further investigation.
A previous study reported that the homodimerization of
the Alx1 is necessary for its transcription activity [22].
Figure 4 Reporter gene assays of the fusion sequences from
derivative chromosome 12 and corresponding normal
chromosome 12 sequences. (A) In the CHO cells, the construct
containing the fusion sequences had luciferase activity about 1.5-
fold higher than that of the construct that contained the normal
sequences. (B) Similarly, in SKNSH cells, the construct containing the
fusion sequences had luciferase activity about two times higher
than that of the construct that contained the normal sequences.
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forms of the Alx1 that were generated by alternative
splicing from rat chondrosarcoma. These two additional
isoforms competed with the wild-type Alx1, exerting a
dominant negative effect. Brouwer et al. also reported
that expression of mutant Alx1 cDNA with the deletion
of the aristaless-domain resulted in severe cranial and
vertebral abnormalities, supporting a dominant negative
role or gain-of-function of certain mutations in the Alx1
gene [23]. Hence, we speculate that the over-expression
of ALX1 might have a dominant negative or gain-of-
function effect and result in the clinical phenotypes of
this family. The clinical features associated with the
over-expression of the ALX1 gene have not yet been
reported in the literature; the family reported in the pre-
sent study might be the first to indicate that increased
expression of the ALX1 gene may lead to microcephaly,
language delay, and mental retardation. Our findings
may expand the clinical spectrum of ALX-related gene
mutations in humans.
Notably, the association between the translocation and
the clinical presentations in this family should be inter-
preted with caution. As an alternative, it is likely that
the concurrence of the translocation in the affected
family members might be due just to chance. In addi-
tion, the maternal grandmother of this family was
reported to have mental retardation too; and the
affected mother had a younger brother who was
reported to have normal intelligence. However, neither
of them was available for investigation of the origin of
the translocation, which is a limitation of this study.
Conclusion
We identified a reciprocal translocation t(1;12)(p32.1;
q21.3) that co-segregates with microcephaly, language
delay, and mental retardation in a two-generation family.
The mapping and characterization of the breakpoint
sequences suggest that the translocation may enhance
t h eg e n ee x p r e s s i o no ft h eA L X 1v i at h ep o s i t i o ne f f e c t
and may thus lead to clinical phenotypes of this family.
Acknowledgements
The study was supported by grants from the National Health Research
Institutes and the National Science Council, Taiwan.
This research was conducted under the Graduate Program of Biotechnology
in Medicine sponsored by the National Tsing Hua University and the
National Health Research Institutes.
Author details
1Institute of Biotechnology, National Tsing-Hua University, Hsinchu, Taiwan.
2Department of Molecular Biology and Human Genetics, Tzu-Chi University,
Hualien, Taiwan.
3Department of Life Sciences and Institute of Genome
Sciences, National Yang-Ming University, Taipei, Taiwan.
4Department of
Teaching and Research, Taipei City Hospital, Taipei, Taiwan.
5Division of
Mental Health and Addiction Medicine, Institute of Population Health
Sciences, National Health Research Institutes, Zhunan, Taiwan.
6Institute of
Medical Sciences, Tzu-Chi University, Hualien, Taiwan.
7Department of
Psychiatry, Chang Gung Memorial Hospital at Linkou and Chang Gung
University School of Medicine, Taoyuan, Taiwan.
Authors’ contributions
HML conducted the long-range PCR and sequencing; JSF and KFL
conducted the karyotype analysis; YJC conducted the FISH analysis; KLW
conducted the reporter gene assay; CHC recruited and evaluated the clinical
phenotypes of the family and supervised the study; he also wrote the draft
of the manuscript that was revised and approved by all the authors.
Competing interests
The authors declare that they have no competing interests.
Received: 9 September 2010 Accepted: 20 May 2011
Published: 20 May 2011
References
1. Leonard H, Wen X: The epidemiology of mental retardation: challenges
and opportunities in the new millennium. Ment Retard Dev Disabil Res Rev
2002, 8(3):117-134.
2. Stevenson RE, Schwartz CE: X-linked intellectual disability: unique
vulnerability of the male genome. Dev Disabil Res Rev 2009, 15(4):361-368.
3. Ropers HH: Genetics of early onset cognitive impairment. Annu Rev
Genomics Hum Genet 2010, 11:161-187.
4. Rauch A, Hoyer J, Guth S, Zweier C, Kraus C, Becker C, Zenker M,
Huffmeier U, Thiel C, Ruschendorf F, et al: Diagnostic yield of various
genetic approaches in patients with unexplained developmental delay
or mental retardation. Am J Med Genet A 2006, 140(19):2063-2074.
5. Abeysinghe SS, Stenson PD, Krawczak M, Cooper DN: Gross Rearrangement
Breakpoint Database (GRaBD). Hum Mutat 2004, 23(3):219-221.
6. Bache I, Hjorth M, Bugge M, Holstebroe S, Hilden J, Schmidt L, Brondum-
Nielsen K, Bruun-Petersen G, Jensen PK, Lundsteen C, et al: Systematic re-
examination of carriers of balanced reciprocal translocations: a strategy
to search for candidate regions for common and complex diseases. Eur J
Hum Genet 2006, 14(4):410-417.
7. Kleinjan DJ, van Heyningen V: Position effect in human genetic disease.
Hum Mol Genet 1998, 7(10):1611-1618.
8. Griggs BL, Ladd S, Saul RA, DuPont BR, Srivastava AK: Dedicator of
cytokinesis 8 is disrupted in two patients with mental retardation and
developmental disabilities. Genomics 2008, 91(2):195-202.
9. Laumonnier F, Roger S, Guerin P, Molinari F, M’Rad R, Cahard D, Belhadj A,
Halayem M, Persico AM, Elia M, et al: Association of a functional deficit of
the BKCa channel, a synaptic regulator of neuronal excitability, with
autism and mental retardation. Am J Psychiatry 2006, 163(9):1622-1629.
10. Kalscheuer VM, FitzPatrick D, Tommerup N, Bugge M, Niebuhr E,
Neumann LM, Tzschach A, Shoichet SA, Menzel C, Erdogan F, et al:
Mutations in autism susceptibility candidate 2 (AUTS2) in patients with
mental retardation. Hum Genet 2007, 121(3-4):501-509.
11. Menten B, Buysse K, Vermeulen S, Meersschaut V, Vandesompele J, Ng BL,
Carter NP, Mortier GR, Speleman F: Report of a female patient with
mental retardation and tall stature due to a chromosomal
rearrangement disrupting the OPHN1 gene on Xq12. Eur J Med Genet
2007, 50(6):446-454.
12. Marco EJ, Abidi FE, Bristow J, Dean WB, Cotter P, Jeremy RJ, Schwartz CE,
Sherr EH: ARHGEF9 disruption in a female patient is associated with ×
linked mental retardation and sensory hyperarousal. J Med Genet 2008,
45(2):100-105.
13. Zaki M, Shehab M, El-Aleem AA, Abdel-Salam G, Koeller HB, Ilkin Y, Ross ME,
Dobyns WB, Gleeson JG: Identification of a novel recessive RELN
mutation using a homozygous balanced reciprocal translocation. Am J
Med Genet A 2007, 143A(9):939-944.
14. Uz E, Alanay Y, Aktas D, Vargel I, Gucer S, Tuncbilek G, von Eggeling F,
Yilmaz E, Deren O, Posorski N, et al: Disruption of ALX1 causes extreme
microphthalmia and severe facial clefting: expanding the spectrum of
autosomal-recessive ALX-related frontonasal dysplasia. Am J Hum Genet
2010, 86(5):789-796.
15. Kleinjan DA, van Heyningen V: Long-range control of gene expression:
emerging mechanisms and disruption in disease. Am J Hum Genet 2005,
76(1):8-32.
16. Velagaleti GV, Bien-Willner GA, Northup JK, Lockhart LH, Hawkins JC,
Jalal SM, Withers M, Lupski JR, Stankiewicz P: Position effects due to
Liao et al. BMC Medical Genetics 2011, 12:70
http://www.biomedcentral.com/1471-2350/12/70
Page 7 of 8chromosome breakpoints that map approximately 900 Kb upstream and
approximately 1.3 Mb downstream of SOX9 in two patients with
campomelic dysplasia. Am J Hum Genet 2005, 76(4):652-662.
17. Cai RL: Human CART1, a paired-class homeodomain protein, activates
transcription through palindromic binding sites. Biochem Biophys Res
Commun 1998, 250(2):305-311.
18. Zhao GQ, Zhou X, Eberspaecher H, Solursh M, de Crombrugghe B:
Cartilage homeoprotein 1, a homeoprotein selectively expressed in
chondrocytes. Proc Natl Acad Sci USA 1993, 90(18):8633-8637.
19. Zhao Q, Behringer RR, de Crombrugghe B: Prenatal folic acid treatment
suppresses acrania and meroanencephaly in mice mutant for the Cart1
homeobox gene. Nat Genet 1996, 13(3):275-283.
20. Twigg SR, Versnel SL, Nurnberg G, Lees MM, Bhat M, Hammond P,
Hennekam RC, Hoogeboom AJ, Hurst JA, Johnson D, et al: Frontorhiny, a
distinctive presentation of frontonasal dysplasia caused by recessive
mutations in the ALX3 homeobox gene. Am J Hum Genet 2009,
84(5):698-705.
21. Kayserili H, Uz E, Niessen C, Vargel I, Alanay Y, Tuncbilek G, Yigit G,
Uyguner O, Candan S, Okur H, et al: ALX4 dysfunction disrupts
craniofacial and epidermal development. Hum Mol Genet 2009,
18(22):4357-4366.
22. Furukawa K, Iioka T, Morishita M, Yamaguchi A, Shindo H, Namba H,
Yamashita S, Tsukazaki T: Functional domains of paired-like homeoprotein
Cart1 and the relationship between dimerization and transcription
activity. Genes Cells 2002, 7(11):1135-1147.
23. Brouwer A, ten Berge D, Wiegerinck R, Meijlink F: The OAR/aristaless
domain of the homeodomain protein Cart1 has an attenuating role in
vivo. Mech Dev 2003, 120(2):241-252.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2350/12/70/prepub
doi:10.1186/1471-2350-12-70
Cite this article as: Liao et al.: Clinical and molecular characterization of
a transmitted reciprocal translocation t(1;12)(p32.1;q21.3) in a family co-
segregating with mental retardation, language delay, and microcephaly.
BMC Medical Genetics 2011 12:70.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Liao et al. BMC Medical Genetics 2011, 12:70
http://www.biomedcentral.com/1471-2350/12/70
Page 8 of 8